Medline Inc.

Equities

MDLN

US58507V1070

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 11:59:43 11/02/2026 pm IST			5-day change	1st Jan Change
45.40 ^USD	+0.25%		+0.17%	+7.25%

06/02	Carlyle allays software fears, private-equity deals boost profit	RE
05/02	Tigress Initiates Medline at Buy With $55 Price Target	MT

Sector Update: Health Care Stocks Mixed Late Afternoon

Published on 01/13/2026 at 02:20 am IST

MT Newswires

Latest news about Medline Inc.

06/02	Carlyle allays software fears, private-equity deals boost profit	RE
05/02	Tigress Initiates Medline at Buy With $55 Price Target	MT
03/02	TD Cowen Initiates Coverage on Medline With Buy Rating, $46 Price Target	MT
29/01	Nasdaq profit beats estimates; CEO touts IPO pipeline	RE
24/01	Goldman Sachs CEO David Solomon's 2025 compensation rises over 20%	RE
15/01	Medline Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:00 PM
13/01	Ranpak Expands Automation, Packaging Partnership With Medline	MT
13/01	JPMorgan profit beats estimates on trading boom, shares hit by weaker investment banking	RE
13/01	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
13/01	Sector Update: Health Care	MT
13/01	FTI Consulting, Inc. Appoints Dan Scorpio and Heather Wilson as Senior Managing Directors	CI
12/01	Medline Poised to Leverage Business Model to Outsized Performance, RBC Says	MT
12/01	Medline Poised to Sustain High-Single Digit Organic Growth, BofA Says	MT
12/01	Morgan Stanley Initiates Coverage on Medline With Overweight Rating, $48 Price Target	MT
12/01	Leerink Partners Initiates Coverage on Medline With Outperform Rating, $48 Price Target	MT
12/01	Piper Sander Initiates Coverage on Medline With Overweight Rating, $50 Price Target	MT
12/01	Goldman Sachs Initiates Coverage on Medline With Buy Rating, $49 Price Target	MT
12/01	BMO Capital Initiates Coverage on Medline With Outperform Rating, $45 Price Target	MT
12/01	Jefferies Initiates Coverage on Medline With Buy Rating, $50 Price Target	MT
12/01	Stifel Nicolaus Initiates Coverage on Medline With Buy Rating, $46 Price Target	MT
12/01	UBS Initiates Coverage on Medline With Buy Rating, $48 Price Target	MT
12/01	JPMorgan Initiates Coverage on Medline With Overweight Rating, $50 Price Target	MT
12/01	Baird Initiates Coverage on Medline With Outperform Rating, $48 Price Target	MT
12/01	Rothschild & Co Redburn Initiates Coverage on Medline With Neutral Rating, $42 Price Target	MT
12/01	Barclays Initiates Coverage on Medline With Overweight Rating, $50 Price Target	MT